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ABSTRACT
Background and Objectives: The relationship between metabolic stress, inflammation, 
and cardiovascular disease is being studied steadily. The aim of this study was to evaluate 
the effect of palmitate (PA) and minimally modified low-density lipoprotein (mmLDL) on 
macrophages and to identify the associated pathways.
Methods: J774 macrophages were incubated with PA or mmLDL and lipopolysaccharide 
(LPS). Secretion of inflammatory chemokines and the expression of corresponding genes 
were determined. The phosphorylation of extracellular signal-regulated kinase (ERK) 
mitogen-activated protein kinase was also assessed. RNA sequencing of macrophages was 
performed to identify the genes regulated by PA or mmLDL. Some of the genes regulated by 
the 2 agents were validated by knocking down the cells using small interfering RNA.
Results: PA or mmLDL promoted the secretion of interleukin (IL)-6 and IL-1β in LPS-
stimulated macrophages, and this was accompanied by higher phosphorylation of ERK. RNA 
sequencing revealed dozens of genes that were regulated in this process, such as Csf3 and 
Edn1, which were affected by PA and mmLDL, respectively. These agents also increased Nlrp3 
expression. The effect of Csf3 or Edn1 silencing on inflammation was modest, whereas toll-like 
receptor (TLR) 4 inhibition reduced a large proportion of macrophage activation.
Conclusions: We demonstrated that the proinflammatory milieu with high levels of PA or 
mmLDL promoted macrophage activation and the expression of associated genes such as Nlrp3, 
Csf3, and Edn1. Although the TLR4 pathway appeared to be most relevant, additional role of 
other genes in this process provided insights regarding the potential targets for intervention.
Keywords: Atherosclerosis; Metabolic syndrome; Immunity; Obesity
INTRODUCTION
Oxidative stress, inflammation, and immune system activation are known to be closely 
related to metabolic disorders such as diabetes, obesity, and associated cardiovascular 
complications.1) When atherosclerosis develops, metabolic stress may significantly affect the 
inflammatory response of endothelial cells, monocytes, and macrophages.2) Although the 
mechanism is not completely understood, diverse types of oxidized low-density lipoproteins 
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(LDLs) are have also been shown to contribute to steatohepatitis. Thus, intervention or 
inhibition of certain metabolic pathways is being considered as a therapeutic option against 
inflammatory disorders.3)
Saturated fatty acids and oxidized LDL commonly coexist and contribute to vascular 
inflammation. Saturated fatty acids can induce inflammatory response via the toll-
like receptor (TLR) 4 pathways, and can affect lipopolysaccharide (LPS) production via 
modification of gut microbiota. Subsequent endotoxemia may trigger oxidative stress and 
result in the production of oxidized LDL, a major form of atherogenic lipids.4) We chose 
palmitate (PA) in this study, as it is a major form of saturated fatty acid in human circulation, 
and it is a player in metabolically pathologic conditions like insulin resistance.5) Several 
studies have reported metabolic inflammation caused by PA.5)6)
The purpose of this study was to evaluate proinflammatory effects and to identify genes 
regulated by metabolic stimuli, saturated fatty acids or modified LDL. Specifically, we 
aimed to examine the effects of PA and minimally modified LDL (mmLDL) on LPS-primed 
macrophages with pivotal roles in chronic inflammatory conditions, such as atherosclerosis. 
We also investigated the genes regulated in this process and validated the expression of 
some of them. Our targets included NLRP3, an essential mediator of the interleukin (IL)-1 
pathway, which is currently being actively investigated. The IL-1 pathway upregulated in 
vascular inflammation, is one of key pathways suggested as a target for anti-inflammatory 
therapy. For example, the CANTOS clinical trial showed that an IL-1β antagonist reduced 
cardiovascular risk.7) Building on our previous research on the combined effects of PA and 
mmLDL,8) we sought to further investigate the individual effects of these 2 agents and 
genes associated with the observed effects in the current study.
METHODS
Macrophages and other reagents
Dulbecco's modified Eagle's medium (DMEM), penicillin-streptomycin, fetal bovine serum 
(FBS) and Dulbecco's phosphate-buffered saline were purchased from Gibco (Grand Island, 
NY, USA). The murine macrophage-like cell line J774A.1 (abbreviated as J774) was provided 
by Yury I Miller in University of California, San Diego, USA. LPS and PA were purchased from 
Sigma-Aldrich (St. Louis, MO, USA) for macrophage stimulation. U0126, an extracellular 
signal-regulated kinase (ERK) inhibitor, was purchased from Cell Signaling Technology 
(Danvers, MA, USA). It was dissolved in dimethyl sulfoxide (DMSO), and a stock solution 
of 10 mM was prepared before experiments. TAK-242, a TLR4 inhibitor, was purchased 
from InvivoGen (San Diego, CA, USA). PA was dissolved in 0.1 M 70% ethanol and a control 
solution containing ethanol was also prepared. TAK-242 was dissolved in DMSO. Stock 
solutions of 30 mM PA and 10 mM TAK-242 were prepared before the experiment. LDL 
(density, 1.019−1.063 g/mL) was isolated from the plasma of healthy donors using sequential 
ultracentrifugation.9) To produce mmLDL, 50 µg/mL LDL was incubated in serum-free 
DMEM for 18 hours with murine fibroblast cells overexpressing human 15-lipoxygenase.8) 
mmLDL has been characterized in detail previously.10) Preparations of PA and mmLDL were 
assessed for LPS contamination using the Limulus amebocyte lysate assay (Lonza, Basel, 
Switzerland). Endotoxin levels were < 0.05 EU/mL in all experiments. We chose 100 µM 
PA8)11)12) and 50 µM/mL mmLDL8)13) for the experiment as these doses have frequently been 
used to test effects of PA or mmLDL on macrophages in previous studies.
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Cell culture and treatment
J774 cells were maintained in DMEM supplemented with 10% FBS and 1% penicillin- 
streptomycin (Gibco, Carlsbad, CA, USA) at 37°C in a 5% CO2 environment. Prior to 
stimulation, the cells were maintained in serum-poor (0.5% FBS) medium for 6 hours. For 
protein expression analysis, J774 cells were plated (5 × 105 cells/well) on 60-mm 6-well plates 
and incubated overnight. The cells were then either not treated or treated with 100 µM PA for 
18 hours before being stimulated with 3 ng/mL LPS. Otherwise, the cells were treated with 3 
ng/mL LPS with or without 50 µg/mL mmLDL for 6 hours. After 30 minutes, the cells were 
harvested for immunoblotting. The supernatant was collected 6 hours post-treatment with 
LPS with or without mmLDL, and then analyzed using enzyme-linked immunosorbent assay 
(ELISA). For quantitative polymerase chain reaction (qPCR) analysis, cells were harvested 6 
hours post-treatment with LPS with or without mmLDL. All experiments were conducted in 
biological triplicates.
Enzyme-linked immunosorbent assay
The cell culture supernatant was collected and the amounts of secreted IL-6, IL-1β, or tumor 
necrosis factor (TNF)-α were quantified using ELISA kits (R & D Systems, Minneapolis, MN, 
USA) according to the manufacturer's protocols. Technical duplicates of all samples were used.
Immunoblot analysis
Cells were harvested and solubilized in radioimmunoprecipitation assay buffer (Biosesang, 
Seongnam, Korea) containing a protease inhibitor cocktail (Roche, Inc., Indianapolis, IN, 
USA). We determined the protein concentration using a bicinchoninic acid protein assay 
(Pierce Biotechnology, Inc., Rockford, IL, USA). Cell lysates were resolved using 10% sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis and then transferred to a polyvinylidene 
difluoride membrane (EMD Millipore, Billerica, MA, USA). The membrane was then 
incubated at room temperature for 1 hour with 5% bovine serum albumin in Tris-buffered 
saline (TBS) solution with Tween-20 and with a primary antibody overnight at 4°C. On the 
following day, the membranes were washed with TBS and incubated with a horse radish 
peroxidase-conjugated secondary antibody at room temperature. The immunoreactive bands 
were visualized using the enhanced chemiluminescence kit (EMD Millipore).
RNA extraction and real-time polymerase chain reaction
RNA was extracted from cells using a Ribospin RNA extraction kit (GeneAll, Seoul, 
Korea) according to the manufacturer's protocol. RNA concentration and purity were 
assessed using a NanoDrop spectrophotometer. One microgram of RNA was then used for 
complementary DNA (cDNA) synthesis with a QuantiTect reverse transcription kit (Qiagen, 
Venlo, Netherlands). Real-time polymerase chain reaction (PCR) was performed using the 
SYBR dye system and Step One Plus real-time PCR machine (Applied Biosystems, Foster City, 
CA, USA). Gene expression analysis was performed using the LightCycler software based on 
cycle threshold values and is shown as fold change of expression. Messenger RNA (mRNA) 
levels were normalized to glyceraldehyde 3-phosphate dehydrogenase mRNA. All results were 
derived from technical duplicates.
RNA sequencing and analysis
RNA purity was determined using a NanoDrop ND1000 spectrophotometer. Total RNA 
sequencing libraries were prepared according to the manufacturer's instructions using a 
Truseq stranded total RNA sample prep kit (Illumina, San Diego, CA, USA). One microgram 
of total RNA was further treated for ribosomal RNA (rRNA) depletion using Ribo-zero 
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rRNA removal kit (human/mouse/rat) (Illumina). Then, the rRNA-depleted total RNA was 
fragmented into small pieces at 94°C for 8 minutes. The cleaved RNA fragments were copied 
to first strand cDNA using reverse transcriptase and random primers. This was followed 
by second strand cDNA synthesis using DNA polymerase I and RNase H. Finally, one 'A' 
base was added, and the adapter was subsequently ligated. The products were purified and 
enriched using PCR to create the final cDNA library. After real-time PCR, index-tagged 
libraries were combined in equimolar ratio. RNA sequencing was performed using the 
Illumina NextSeq 500 platform according to the manufacturer's recommended protocol.
The reads were aligned with the gene expression values using Cufflinks (fragments per kilobase 
of transcript per million mapped reads). The differentially expressed genes of the vehicle 
treatment group were compared to that of the PA or mmLDL treatment group using Cuffdiff. 
Upregulated or downregulated genes with q-value <0.05 and 2-fold change were identified.
Small interfering RNA transfection
Small interfering RNAs (siRNAs) against Csf3r and Edn1 and the scrambled siRNA were 
purchased from Mbiotech (Hanam, Korea). For gene silencing, J774 cells were treated with 
100 nM siRNA using Lipofectamine RNAiMax (Invitrogen, Carlsbad, CA, USA). After 24 
hours, the media with siRNA were removed and stimulants were treated for each experiment.
Statistical analysis
All data are presented as the mean±standard error of the mean. We performed t-test for 
comparison between groups. p<0.05 (2-sided) was considered statistically significant. We used the 
software package Prism 5.0 for all data analyses (GraphPad Software Inc., San Diego, CA, USA).
RESULTS
Palmitate or minimally modified low-density lipoprotein promoted 
chemokine secretion in macrophages
To evaluate the effect of PA on chemokine secretion in LPS-stimulated macrophages, 
macrophages were incubated with PA and treated with or without LPS. ELISA showed that 
the cells treated with PA and LPS secreted significantly more IL-6 and IL-1β in the culture 
media than the cells treated with LPS alone (Figure 1A). To determine the effect of mmLDL, 
macrophages were treated with LPS with or without mmLDL. IL-6 and IL-1β secretion in the 
culture media was higher in cells treated with mmLDL and LPS than in cells treated with LPS 
alone (Figure 1B).
J774 cells were incubated with PA and then treated with or without LPS. The relative 
expression of Il6 and Il1b were determined using qPCR and normalized to that of Gapdh. 
Compared to that in LPS alone, both genes were upregulated by co-treatment with PA and 
LPS (Figure 1C). Next, the cells were treated with LPS with or without mmLDL. The mRNA 
levels of Il6 and Il1b increased significantly in cells treated with mmLDL and LPS compared to 
those treated with LPS alone (Figure 1D).
Palmitate or minimally modified low-density lipoprotein promoted 
extracellular signal-regulated kinase activation in macrophages
The J774 cells were incubated with PA and then treated with or without LPS. Immunoblotting 
using cell extracts showed higher ERK phosphorylation in cells treated with PA and LPS 
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than in those treated with LPS alone (Figure 2A). The macrophages were treated with LPS 
with or without mmLDL. The cells treated with mmLDL and LPS showed higher ERK 
phosphorylation than those treated with LPS alone (Figure 2B). TLR4 and MyD88, upstream 
of ERK mitogen-activated protein kinase (MAPK), were analyzed after treatment of LPS with 
or without PA or mmLDL in the same manner described above. We found that PA increased 
TLR4 expression (Figure 2C), whereas mmLDL upregulated TLR4 and MyD88 (Figure 2D). 
To validate the role of ERK in the action of PA or mmLDL, J774 cells were incubated with 
U0126, an ERK inhibitor, or DMSO for 2 hours and then treated with LPS with or without 
PA or mmLDL. PA-induced elevation of IL-6 and IL-1β secretion was significantly reduced by 
ERK inhibition with U0126 (Figure 2E and F). Conversely, U0126 significantly only attenuated 
mmLDL-induced elevation of IL-1β secretion (Figure 2F).
Genes regulated by palmitate or minimally modified low-density lipoprotein
To identify the genes regulated by PA or mmLDL, the mRNA profiles of the cells were 
analyzed using RNA sequencing. Compared to the cells stimulated with LPS alone, those 
stimulated with PA and LPS showed nine differentially expressed and upregulated genes. The 
cells stimulated with mmLDL and LPS showed 30 differentially expressed upregulated genes 
(Table 1).
Among the target genes regulated by PA, we selected Csf3 for validation. Csf3 is expressed 
in diverse immune cells and is involved in the maturation of granulocytes and modulation 
of immune response.14) Among the target genes regulated by mmLDL, we selected Edn1 
for validation. Although its role in macrophages is not clear, it is known to be involved 
in inflammation in endothelial cells and affect the transcription of inflammatory 
chemokines.15)16)
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Figure 1. Chemokine secretion and the corresponding mRNA levels increased additively after treatment with PA or mmLDL in LPS-stimulated J774 macrophages. 
Macrophages were incubated with PA, followed by treatment with or without LPS. The culture media was collected and the levels of IL-6 and IL-1β were 
determined using ELISA (A). Macrophages were treated with LPS with or without mmLDL. The culture media were collected and the levels of IL-6 and IL-1β were 
determined (B). J774 cells were incubated with PA, followed by treatment with or without LPS. The cells were harvested and the relative expression levels of 
Il6 and Il1b were determined using qPCR and normalized to that of Gapdh (C). J774 cells were treated with LPS with or without mmLDL. mRNA expression was 
determined as mentioned above (D). Experiments were conducted with technical duplicates, and data presented are based on 3 independent replicates. 
ELISA = enzyme-linked immunosorbent assay; IL = interleukin; LPS = lipopolysaccharide; mmLDL = minimally modified low-density lipoprotein; mRNA = 
messenger RNA; PA = palmitate. 
*p<0.05, †p<0.01, ‡p<0.001.
Validation of the role of Csf3 in macrophage activation by palmitate
To validate the RNA sequencing results, the mRNA level of Csf3 in macrophages was determined 
after PA treatment. J774 cells were incubated with PA and then treated with or without LPS. The 
relative expression of Csf3 in cells treated with PA and LPS was more than that of cells treated with 
LPS alone (Figure 3A). CSF3 is the primary ligand for CSF3R, a member of the cytokine receptor 
superfamily. To analyze the role of CSF3R in PA-associated macrophage activation, we determined 
the changes in chemokine secretion after silencing of Csf3r. J774 cells were transfected with siRNA 
against Csf3r prior to stimulation with PA with or without LPS. ELISA of the culture media showed 
significant attenuation of the elevated IL-6 and IL-1β secretion (Figure 3B).
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Figure 2. Phosphorylation of ERK MAPK and its upstream targets were additively promoted by PA or mmLDL in LPS-stimulated macrophages. J774 cells were 
incubated with PA and then treated with or without LPS. Cell extracts were collected and phosphorylation of ERK was analyzed using immunoblotting (A). 
Macrophages were treated with LPS with or without mmLDL. Phosphorylation of ERK was analyzed as mentioned above (B). TLR4 and MyD88, the upstream 
molecules of ERK MAPK, were analyzed after treatment LPS with or without PA (C) or mmLDL (D). J774 cells were incubated with U0126, an ERK inhibitor, or 
DMSO and then treated with or without PA or mmLDL. The effect of U0126 on PA or mmLDL-induced elevation of IL-6 (E) and IL-1β (F) secretion was analyzed. 
Experiments were conducted with technical duplicates, and data presented are based on 3 independent replicates. 
ANOVA = analysis of variance; DMSO = dimethyl sulfoxide; ERK = extracellular signal-regulated kinase; IL = interleukin; LPS = lipopolysaccharide; MAPK = 
mitogen-activated protein kinase; mmLDL = minimally modified low-density lipoprotein; NS = not significant; PA = palmitate; TLR = toll-like receptor. 
*p<0.05, †p<0.01.
Validation of the role of Edn1 in macrophage activation by minimally modified 
low-density lipoprotein
To validate the results of RNA sequencing, the Edn1 mRNA level in macrophages was 
determined after mmLDL treatment. Macrophages were treated with LPS with or without 
mmLDL. The relative expression of Edn1 in cells treated with mmLDL and LPS was higher 
than that in cells treated with LPS alone (Figure 4A). Silencing of Edn1 did not attenuate the 
increased IL-6 and IL-1β secretion, whereas it reduced the secretion of TNF-α (Figure 4B).
Role of the NLRP3 and TLR4 pathways in macrophage activation
We have observed upregulation of Il1b, a well-known inflammation-related gene, after PA 
or mmLDL treatment (Figure 1). Hence, we sought to evaluate whether these agents acted 
via the NLRP3-dependent pathway. The results of real-time PCR showed that Nlrp3, the 
expression of which tended to increase after PA or mmLDL treatment in RNA sequencing, 
was significantly upregulated (Figure 5A). Finally, we investigated whether the increased 
secretion and expression of IL-1β was dependent on the TLR4 pathway. TAK-242, a TLR4 
inhibitor, appeared to reduce, albeit not significantly, the elevated secretion of IL-1β with 
PA or mmLDL (top of Figure 5B). However, after TAK-242 treatment, we observed that the 
induction of Il1b with PA or mmLDL was remarkably attenuated (bottom of Figure 5B).
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Fold change Fold change
Pus2f2 3.21 Thbs1 8.10
Tgfbi 2.68 Il1a 6.78
Il1f9 2.59 Slc39a10 5.35
Edil3 2.33 Nr4a1 5.14
C1pc 2.21 Tnfsf9 4.52
Csf3 2.21 Osbp2 4.42
Cd3001b 2.18 Dusp5 4.25
Cd93 2.15 Cd93 4.07






















LPS = lipopolysaccharide; mmLDL = minimally modified low-density lipoprotein; PA = palmitate.
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Figure 3. Role of Csf3 in macrophage activation after treatment with PA. To validate the results of RNA sequencing, the Csf3 mRNA level in macrophages was determined 
after PA treatment. J774 cells were incubated with PA and then treated with or without LPS. The cells were harvested and the relative expression of Csf3 was measured 
using qPCR and normalized to Gapdh expression (A). Silencing of Csf3r attenuated the PA-induced increased secretion of chemokines in LPS-stimulated macrophages. 
J774 cells were transfected with siRNA against Csf3r prior to stimulation of the cells with PA with or without LPS. In the culture media, the levels of chemokines were 
determined using ELISA. Experiments were conducted with technical duplicates, and data presented are based on 3 independent replicates. 
ELISA = enzyme-linked immunosorbent assay; IL = interleukin; LPS = lipopolysaccharide; mmLDL = minimally modified low-density lipoprotein; mRNA = 






















































































































Figure 4. Role of Edn1 in macrophage activation after treatment with mmLDL. To validate the results of RNA sequencing, Edn1 mRNA expression in macrophages 
was determined after treatment with mmLDL. J774 cells were treated with LPS with or without mmLDL. The relative expression of Edn1 was determined using 
qPCR and normalized to Gapdh expression (A). J774 cells were transfected with siRNA against Edn1 prior to stimulation of the cells with mmLDL with or without 
LPS. The chemokine levels in the culture media of J774 cells was determined using ELISA. Edn1 silencing did not attenuate the increased secretion of IL-6 and IL-
1β, whereas it reduced that of TNF-α. Experiments were conducted with technical duplicates, and data presented are based on 3 independent replicates. 
ELISA = enzyme-linked immunosorbent assay; IL = interleukin; LPS = lipopolysaccharide; mmLDL = minimally modified low-density lipoprotein; mRNA = 
messenger RNA; NS = not significant; qPCR = quantitative polymerase chain reaction; siRNA = small interfering RNA; TNF = tumor necrosis factor. 
*p<0.05, †p<0.01.
DISCUSSION
The findings of our study include: 1) PA or mmLDL promoted inflammatory chemokine 
secretion in LPS-stimulated macrophages. 2) This was accompanied by the activation of the 
ERK MAP kinase pathway. 3) Dozens of PA and mmLDL-regulated genes were identified, 
which included Csf3 and End1, respectively. 4) Nlrp3 was also found to be activated by these 
2 agents. 5) The effect of silencing either Csf3 or Edn1 appeared to be modest, whereas TLR4 
inhibition reduced a large proportion of macrophage activation by PA or mmLDL. In this 
study, we demonstrated the effect of the proinflammatory metabolic milieu on macrophages 
and the associated molecular pathways.
We demonstrated, for the first time, that mmLDL can upregulate Nlrp3. Although the TLR4 
pathway appeared to contribute the most to this process, evidence on the role of other genes 
was also provided. The strength of the current study also relies on the identification of genes 
regulated by PA or mmLDL. These can be suggested as novel therapeutic targets against poor 
metabolic conditions. It has been reported that PA could promote insulin resistance and 
inflammation via TLR4-dependent and some other pathways.17) However, we are the first to 
provide data demonstrating that Csf3 is upregulated by PA. Conversely, the pathways on which 
oxidized LDL works have been substantially investigated and understood, particularly, oxidized 
LDL's interactions with CD36 and its influence on inflammasomes.18) Remarkably, however, we 
revealed that mmLDL not containing advanced lipid oxidation products upregulates Nlrp3.
The NLRP3 inflammasome is a well-known signaling complex involved in innate immunity 
and is a key mediator of the production of IL-1 family of cytokines. It is activated by various 
endogenous signals during the progression of atherosclerosis, which include pathogen-
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Figure 5. Involvement of the NLRP3 and the TLR4-mediated pathway in macrophage activation with PA or mmLDL. J774 cells were treated with PA or mmLDL in 
addition to LPS. RNA-sequencing showed a tendency of upregulation of Nlrp3 (top of A). Real-time PCR demonstrated significant increase in Nlrp3 expression 
after PA or mmLDL treatment (bottom of A). To investigate the role of the TLR4 pathway in mediating the effects of PA or mmLDL on IL-1β, its expression and 
secretion were determined with or without a TLR4 inhibitor, TAK-242. TAK-242 inhibited, albeit not significantly, the effect of PA or mmLDL-induced IL-1β secretion 
(top of B). However, the effect of PA or mmLDL on Il1b upregulation was remarkably reduced after TLR4 inhibition (bottom of B). 
IL = interleukin; LPS = lipopolysaccharide; mmLDL = minimally modified low-density lipoprotein; NS = not significant; PA = palmitate; PCR = polymerase chain 
reaction; TLR = toll-like receptor. 
*p<0.05.
associated molecular patterns, danger-associated molecular patterns, and oxidized LDL.19) 
Free fatty acids such as PA have been reported to promote NLRP3 production via the pattern 
recognition receptor.19) Oxidized LDL is known to be involved in the formation of the NLRP3 
inflammosome.19)20) This effect of oxidized LDL can also result in disorders not only in 
cardiovascular organs. Uptake of oxidized LDL by Kupffer cells has been reported to induce 
inflammasome activation, impairment of autophagy and hepatic inflammation and non-
alcoholic steatoheaptitis. In addition, activated inflammasome and promoted apoptosis of 
hepatocytes are known to induce inflammation. Furthermore, oxidized LDL can activate 
hepatic stellate cells and leads to pro-fibrotic response.21) However, for the first time, we 
showed that mmLDL upregulated Nlrp3 expression.
Studies have suggested that PA promotes inflammation via multiple pathways, and TLR2 
and TLR4 are considered the major receptors mediating this effect. However, alternative 
mediators such as diacylglycerol, ceramide, and lysophosphatidylcholine also contribute to 
intracellular inflammation by PA. Hence, controlling the response to PA by inhibiting a single 
pathway may be challenging.22) Reports have shown that mmLDL promotes inflammation 
via TLR4.23) Choi et al.24) showed that oxidized cholesteryl ester of mmLDL induces secretion 
of inflammatory cytokines, which is mediated by TLR4 and spleen tyrosine kinase. In our 
study, a TLR4 inhibitor attenuated a large proportion of IL-1β secretion. Thus, we confirmed 
that this pathway can be a target for efficiently controlling macrophage activation with PA or 
mmLDL. We confirmed that PA or mmLDL activated ERK MAPK and upregulated TLR4 in 
LPS-stimulated macrophages. This finding was validated by using ERK inhibitor. However, 
because the activation of ERK by these agents was previously shown and was not the main 
purpose of the current study, we did not further explore ERK-related issues.
In the present study, we observed that silencing of 2 genes, Csf3 and Edn1, modestly but 
significantly reduced the cellular effect of PA and mmLDL, respectively. Csf3 function has 
been reported to be dependent on TLR4.8) This gene is associated with inflammation 
and is upregulated in the epicardial adipose tissue of patients with diabetes and coronary 
artery disease. This suggests that Csf3 expression may be related to metabolism and 
atherosclerosis.25) Furthermore, Csf3 was reported to be one of the differentially expressed 
genes during the dedifferentiation of human smooth muscle cell phenotype, indicating its 
possible relationship with atherogenesis.26) Upregulation of Csf3 by PA in our study implied 
that Csf3-related pathways may contribute to the proinflammatory and proatherogenic 
activities of PA.
We observed that Edn1 was upregulated by mmLDL. A previous human genetic study has 
revealed the association of Edn1 with fibromuscular dysplasia or coronary artery disease.27) 
Edn1 is one of the transcriptionally regulated genes in macrophage response.28) In Cd73-
deficient mice, Edn1 was found to be upregulated and atherosclerosis was promoted.29) The 
extent of mmLDL-mediated upregulation of Edn1 that can contribute to vascular pathology 
remains to be investigated. The other genes affected by PA or mmLDL include, but are not 
limited to, the following: Il1f9, C1qc, and Cd93 were upregulated by PA, whereas Thbs1, Il1a, 
and Slc39a10 were upregulated by mmLDL. However, till date, the role of these genes in 
cardiovascular health remains uncertain.
In our experiments, LPS frequently showed a greater impact than PA or mmLDL on 
chemokine secretion or expression of related genes. However, our focus was on PA or 
mmLDL in LPS-primed macrophages, not to compare any of them. Although an environment 
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with elevated endotoxin, represented by LPS, is of importance,30) our study sought to 
investigate the effect of PA and mmLDL, on top of endotoxemia, which are known mediators 
in poor metabolic conditions.
Our study has a few limitations. The doses of PA or mmLDL used in our study may differ from 
the concentration found in human tissues or in circulation. However, we referred to doses 
used in previous studies, and our dosages were within the published ranges. We validated the 
roles of Csf3 and Edn1, as well as that of TLR4, and observed that the effect of TLR4 inhibition 
was the most obvious. As TLR4, an upstream receptor, plays a major role in these processes, 
the feasibility of using other genes that play minor roles in these processes as intervention 
targets could be uncertain. However, we identified several PA- and mmLDL-affected genes, 
and multiple relevant genes may possibly act cooperatively. In particular, risk factors other 
than saturated fatty acids and modified LDL may coexist in metabolic conditions that are 
prone to vascular diseases. Therefore, an understanding of the diverse risk factors and 
associated targets will be valuable for translating the results of this study into practice.
In conclusion, we demonstrated that proinflammatory metabolic conditions involving 
elevation in PA or mmLDL levels promoted macrophage activation via regulation of the 
expression of various genes such as Nlrp3, Csf3, and Edn1. Although the TLR4 pathway 
appeared to be the most relevant, validation of the role of other genes provided insights 
regarding the potential targets for intervention in this environment.
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